Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Matsuda, Kentaro ^a,b   Narita, Mitsuo ^c   Sera, Nobuyuki ^d   Maeda, Eriko ^d   Yoshitomi, Hideaki ^d   Ohya, Hitomi ^e   Araki, Yuko ^f   Kakuma, Tatsuyuki ^f   Fukuoh, Atsushi ^g   Matsumoto, Kenji ^b  

^a Matsuda Children's Clinic   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c Sapporo Tokushukai Hospital   (Japan)

^d FUKUOKA INSTITUTE OF HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^e KANAGAWA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^f KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g JUNSHIN GAKUEN UNIVERSITY   (Japan)

Author keywords

A2063T; Inflammatory cytokine; Macrolide resistant; Mycoplasma pneumoniae; Predictive factors

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CYTOKINE; ERYTHROMYCIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GATIFLOXACIN; INTERLEUKIN 6; JOSAMYCIN; LEVOFLOXACIN; MACROLIDE; MINOCYCLINE; RNA 23S; ROKITAMYCIN; SPARFLOXACIN; TETRACYCLINE; TOSUFLOXACIN;

23S RRNA GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CHILD; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIDEMIC; FEMALE; FEVER; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; CYTOKINES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INTERLEUKIN-6; JAPAN; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; POINT MUTATION; PREVALENCE;

EID: 84890293676     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-591     Document Type: Article

References (28)

1. Ishida K, Kaku M, Irifune K, Mizukane R, Takemura H, Yoshida R, Tanaka H, Usui T, Suyama N, Tomono K, Ishida K, Kaku M, Irifune K, Mizukane R, Takemura H, Yoshida R, Tanaka H, Usui T, Suyama N, Tomono K. In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. Anti Agents Chem 1994, 38:790-798.
2. Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, Sasaki Y, Arakawa Y, Sasaki T. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Micro Im 2001, 45:617-620.
3. Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, Wang C. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 2010, 51:189-194. 10.1086/653535, 20540621.
4. Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y, Saito A, Kondo E, Teranishi H, Wakabayashi T, Ogita S, Tanaka T, Kawasaki K, Nakano T, Terada K, Ouchi K. Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Anti Agents Chem 2013, 57:4046-4069.
5. Hong KB, Choi EH, Lee HJ, Lee SY, Cho EY, Choi JH, Kang HM, Lee J, Ahn YM, Kang YH, Lee JH. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011. Emerg Infect Dis 2013, 19:1281-1284. 10.3201/eid1908.121455, 3739509, 23876792.
6. Pereyre S, Charron A, Renaudin H, Bébéar C, Bébéar CM. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol 2007, 45:3534-3549. 10.1128/JCM.01345-07, 2168523, 17881549.
7. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Anti Agents Chem 2008, 52:3542-3549.
8. Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strain in Germany. Clin Microbiol Infect 2010, 16:613-616. 10.1111/j.1469-0691.2009.02968.x, 19765022.
9. Yamada M, Buller R, Bledose S, Storch GA. Rising rates of macrolide- resistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J 2012, 31:409-411. 10.1097/INF.0b013e318247f3e0, 22209916.
10. Eshaghi A, Memari N, Tang P, Olsha R, Farrell DJ, Low DE, Gubbay JB, Patel SN. Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011. Emerg Infect Dis 2013, 19:1525-1527.
11. Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, Suzuki I, Andoh T, Kenri T, Sasaki Y, Horino A, Shintani M, Arakawa Y, Sasaki T. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Anti Agents Chem 2004, 48:4624-4630.
12. Morozumi M, Hasegawa K, Kobayashi R, Inoue N, Iwata S, Kuroki H, Kawamura N, Nakayama E, Tajima T, Shimizu K, Ubukata K. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Anti Agents Chem 2005, 49:2302-2306.
13. Suzuki Y, Itagaki T, Seto J, Kaneko A, Abiko C, Mizuta K, Matsuzaki Y. Community outbreak of macrolide-resistant mycoplasma pneumoniae in Yamagata, Japan in 2009. Pediatr Infect Dis J 2012, 32:237-240.
14. Bellau-Pujol S, Vabret A, Legrand L, et al. Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses. J Virol Methods 2005, 126:53-63. 10.1016/j.jviromet.2005.01.020, 15847919.
15. Gröndahl B, Puppe W, Hoppe A, Kühne I, Weigl JA, Schmitt HJ. Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study. J Clin Microbiol 1999, 37:1-7. 84151, 9854054.
16. Lucier TS, Heitzman K, Liu SK, Hu PC. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Anti Agents Chem 1995, 39:2770-2773.
17. Narita M, Okazaki N, Ohya H, Ishida T, Miyashita N, Yamazaki T, Iwata S, Kaku M, Sasaki T. Proposed antibiotic breakpoint on Mycoplasma pneumonia clinical isolates concerning macrolide and lincosamide antibiotics. Jpn J Mycoplasmol 2008, 35:59-60. In Japanese.
18. Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, Nakayama E, Sunakawa K, Ubukata K. Acute Respiratory Diseases Study Group Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Anti Agents Chem 2008, 52:348-350.
19. Lin C, Li S, Sun H, Zhao H, Feng Y, Cao L, Yuan Y, Zhang T. Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China. J Clin Microbiol 2010, 48:4567-4572. 10.1128/JCM.00400-10, 3008430, 20861333.
20. Dégrange S, Cazanave C, Charron A, Renaudin H, Bébéar C, Bébéar CM. Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol 2009, 47:914-923. 10.1128/JCM.01935-08, 2668363, 19204097.
21. Fujii S, Akiyama M, Aoki K, Sugaya Y, Higuchi K, Hiraoka M, Miki Y, Saitoh N, Yoshiyama K, Ihara K, Seki M, Ohtsubo E, Maki H. DNA replication errors produced by the replicative apparatus of Escherichia coli. J Mol Biol 1999, 289:835-850. 10.1006/jmbi.1999.2802, 10369765.
22. Spuesens EB, Hoogenboezem T, Sluijter M, Hartwig NG, van Rossum AM, Vink C. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. J Microbiol Methods 2010, 82:214-222. 10.1016/j.mimet.2010.06.004, 20547188.
23. Narita M, Tanaka H, Yamada S, Abe S, Ariga T, Sakiyama Y. Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection. Clin Diagn Lab Immunol 2001, 8:1028-1030. 96192, 11527824.
24. Tanaka H, Narita M, Teramoto S, Saikai T, Oashi K, Igarashi T, Abe S. Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults. Chest 2002, 121:1493-1497. 10.1378/chest.121.5.1493, 12006434.
25. Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother 2010, 16:78-86. 10.1007/s10156-009-0021-4, 20094751.
26. Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, Matsuoka M, Kenri T, Arakawa Y, Sasaki T. Clinical evaluation of macrolideresistant Mycoplasma pneumoniae. Anti Agents Chem 2006, 50:709-712.
27. Narita M, Tanaka H. Late increase of interleukin-18 levels in blood during Mycoplasma pneumoniae pneumonia. Cytokine 2012, 59:18-19. 10.1016/j.cyto.2012.04.007, 22564533.
28. Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, Ebihara T, Ubukata K, Sato Y, Akita H, Sunakawa K, Iwata S. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother 2009, 15:380-383. 10.1007/s10156-009-0715-7, 20012728.